Physician

Andrew Kovoor, MD

According to 2025 Medicare claims, Andrew Kovoor, MD (NPI: 1407119464) practices hematology/oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Collin, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 75093-5339. Kovoor is affiliated with the Jefferson Accountable Care, LLC (ACO ID: A5275), participating under the MSSP model.

Kovoor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 729 traditional Medicare patients, billed 195,154 HCPCS/CPT codes, and received $3,197,750 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 574 prescription claims across 137 beneficiaries totaling $1,911,559 in drug costs, led by Cabometyx (Cabozantinib S-Malate). 2020 DME data shows 23 claims. Open Payments data shows 91 records totaling $3,258. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $962,228 to $3,197,750. Similarly, Part D prescription costs have risen steadily, from $25,885 to $1,911,559. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.